EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Anti-atherosclerotic properties of nifedipine. Benefit of early intervention to prevent cardiovascular complications



Anti-atherosclerotic properties of nifedipine. Benefit of early intervention to prevent cardiovascular complications



Cardiology 88 Suppl 3: 52-55



Early stages of the atherosclerotic plaque are considered to be responsible for about 2/3 of all acute coronary syndromes. Therefore, suppression of this initial stage of plaque formation constitutes a major target to reduce the incidence of the disease itself as well as its complications. Ca antagonists, like Nifedipine, interfere with Ca++ ions crucially involved in atherogenesis. Consequently, interval angiographic trials with Nifedipine in patients afflicted with coronary artery disease assessed a significant reduction of coronary lesions. Clinical outcome trials will establish the prognostic importance of the anti-atherosclerotic properties of Nifedipine.

(PDF 0-2 workdays service: $29.90)

Accession: 009770103

Download citation: RISBibTeXText

PMID: 9397295



Related references

Early intervention for metabolic complications of HIV. A healthy lifestyle and treatment early on may prevent complications down the road. Positively Aware 17(2): 35-41, 2006

The use of early intervention to prevent postoperative complications. Current Opinion in Critical Care 15(4): 349-354, 2009

Polypharmacy in the elderly. Early intervention can prevent complications. Advance for Nurse Practitioners 5(7): 28-34, 1997

Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events. Atherosclerosis 147(SUPPL 1): S17-S21, Sept 9, 1999

Early management of atrial fibrillation to prevent cardiovascular complications. European Heart Journal 35(22): 1448-1456, 2015

Gastrointestinal complications after cardiac transplantation. Potential benefit of early diagnoses and prompt surgical intervention. Annals of Surgery 211(5): 538-41; Discussion 541-2, 1990

The Benefit from Anti-Inflammatory Properties of Colchicine in Cardiovascular Diseases. American Journal of Cardiology 116(3): 493-493, 2015

Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial. Bmj Open 6(4): E009134-E009134, 2016

Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial. American Heart Journal 152(5): 876-881, 2006

Sleep-disordered breathing does not affect nocturnal dipping, as assessed by pulse transit time, in preschool children: evidence for early intervention to prevent adverse cardiovascular effects?. Sleep Medicine 15(4): 464-471, 2014

Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice. Atherosclerosis 199(2): 295-303, 2007

Antioxidant and anti-apoptotic properties of Kalpaamruthaa in type 2 diabetes mellitus induced cardiovascular complications. Biomedicine & Preventive Nutrition 2(3), 2012

Control hypertension to prevent cardiovascular complications. 24/7 blood pressure control helps reduce stroke risk, especially during the early morning hours, when the incidence is greatest. Heart Advisor 10(11): 4-5, 2008

Evaluation of anti-atherosclerotic and vasculoprotective effect of long acting nifedipine in patients after PTCA. Journal of the Indian Medical Association 99(9): 519-20, 522, 2002

Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases. Zhonghua Fu Chan Ke Za Zhi 37(6): 321-323, 2003